IRIS
LOCATI, LAURA DEBORAH
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.687
NA - Nord America 1.525
EU - Europa 879
SA - Sud America 241
AF - Africa 68
OC - Oceania 4
Totale 4.404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.430
SG - Singapore 504
CN - Cina 416
HK - Hong Kong 268
RU - Federazione Russa 216
VN - Vietnam 195
IT - Italia 184
BR - Brasile 172
FR - Francia 145
DE - Germania 132
BD - Bangladesh 116
GB - Regno Unito 62
IN - India 56
MX - Messico 41
CA - Canada 38
ZA - Sudafrica 34
FI - Finlandia 33
AR - Argentina 25
PL - Polonia 22
TR - Turchia 16
IQ - Iraq 14
ES - Italia 13
MY - Malesia 12
AT - Austria 11
IE - Irlanda 11
JP - Giappone 11
PK - Pakistan 10
CO - Colombia 9
EC - Ecuador 9
UZ - Uzbekistan 9
VE - Venezuela 9
ID - Indonesia 8
NL - Olanda 8
SA - Arabia Saudita 8
CL - Cile 7
EG - Egitto 6
IL - Israele 6
LT - Lituania 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
NO - Norvegia 5
PH - Filippine 5
SE - Svezia 5
TN - Tunisia 5
CZ - Repubblica Ceca 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
NP - Nepal 4
PT - Portogallo 4
PY - Paraguay 4
AU - Australia 3
AZ - Azerbaigian 3
BE - Belgio 3
ET - Etiopia 3
IR - Iran 3
SN - Senegal 3
UY - Uruguay 3
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
LV - Lettonia 2
QA - Qatar 2
UA - Ucraina 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
CY - Cipro 1
GD - Grenada 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
TC - Turks e Caicos 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 4.404
Salva come PNG Salva come JPEG
Città #
San Jose 376
Hong Kong 263
Singapore 233
Dallas 179
Ashburn 136
Beijing 115
Council Bluffs 82
Los Angeles 82
Lauterbourg 71
Hanoi 56
Ho Chi Minh City 55
Munich 50
Redondo Beach 49
New York 43
Moscow 35
Santa Clara 31
Buffalo 28
Falkenstein 28
Johannesburg 28
Mexico City 28
Turku 28
Milan 27
Boardman 24
Orem 22
São Paulo 21
Montreal 19
Warsaw 18
Frankfurt am Main 17
Shanghai 16
Brooklyn 15
Haiphong 15
Chennai 14
Nuremberg 14
Rome 14
Denver 13
London 13
Changsha 12
Dublin 11
Guangzhou 11
Pavia 11
Phoenix 11
Secaucus 11
Atlanta 10
Chicago 10
Da Nang 10
Kuala Lumpur 10
Seattle 10
Tokyo 10
Yiwu 10
Tashkent 9
Dhaka 8
Hyderabad 8
Düsseldorf 7
Houston 7
Novate Milanese 7
Charlotte 6
Elk Grove Village 6
New Delhi 6
Paris 6
San Francisco 6
Toronto 6
Amsterdam 5
Ankara 5
Belo Horizonte 5
Boston 5
Brasília 5
Bến Tre 5
Madrid 5
Manchester 5
Poplar 5
Riyadh 5
Stockholm 5
Suzhou 5
Turin 5
Almaty 4
Amman 4
Baghdad 4
Curitiba 4
Florence 4
Guayaquil 4
Helena 4
Helsinki 4
Kingston 4
Mumbai 4
Pittsburgh 4
Vienna 4
Zhengzhou 4
Addis Ababa 3
Baku 3
Bari 3
Bắc Ninh 3
Campinas 3
Can Tho 3
Dakar 3
Desio 3
Honolulu 3
Kathmandu 3
Montevideo 3
Naples 3
Nha Trang 3
Totale 2.633
Salva come PNG Salva come JPEG
Nome #
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 148
An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial 148
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 124
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 104
Head and Neck Cancer (HNC) Prehabilitation: Advantages and Limitations 91
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor–Expressing Salivary Gland Cancer: A Phase II Trial 80
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients 80
Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination 80
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 79
Vitamin B12 status in hospitalised cancer patients: Prevalence and clinical implications of depletion and hypervitaminosis 79
Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation 78
Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study 76
A small bowel adenocarcinoma harboring a DDR2 mutation in a celiac patient 73
NR4A3 fusion molecular profile change pathological diagnosis? A case report 71
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 71
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic 68
Charged particle radiotherapy for thyroid cancer. A systematic review 68
Please mind the gap-about equity and access to care in oncology 66
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review 66
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma 64
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer 64
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 62
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 62
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 60
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 59
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 58
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients 58
Adenoid Cystic carcinoma of minor salivary glands (AdCCmSG): a multidisciplinary update 58
Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up 54
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? 53
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area 52
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients 52
Current picture of anaplastic thyroid cancer patients' care and meetable needs: A survey of 94 Institutions from the EORTC Endocrine and Head and Neck Cancer Groups 50
Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study 50
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 49
Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck 49
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 49
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 49
Major and minor salivary gland tumours 48
Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy? 47
International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34 47
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 46
Implementing a virtual multidisciplinary clinical case discussion to manage rare and complex head and neck cancers: an expert-defined protocol proposal from the Italian Association of Head and Neck Oncology (AIOCC) 46
Salivary gland cancers in elderly patients: challenges and therapeutic strategies 46
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 45
The impact of electronic versus paper-based data capture on data collection logistics and on missing scores in thyroid cancer patients 45
Exposure to Occupational Carcinogens and Non-Oncogene Addicted Phenotype in Lung Cancer: Results from a Real-Life Observational Study 45
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 45
Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe 44
Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed 44
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma 43
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib 43
Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era 43
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer 42
How can we address the challenge of distant metastases in HNSCC prognosis? 42
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells 42
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 41
An Old but Still Unanswered Question in Recurrent or Metastatic Salivary Duct Carcinoma 41
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report 41
Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series 40
Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet) 38
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy 38
A novel interface terminology for patient-reported outcomes in home patients monitoring applications 38
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer 38
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 38
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 37
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer 37
Current landscape and support for practical initiation of oncological prehabilitation translatable to thyroid cancer: A position paper 36
Rare Head and Neck Cancers and Pathological Diagnosis Challenges: A Comprehensive Literature Review 36
INDUCTION CHEMOTHERAPY WITHIN A MULTIMODALITYREATMENT OF NASAL CAVITY AND ETHMOID SINUS MALIGNANT EPITHELIAL TUMOURS: REPORT OF AN HOMOGENEOUS SERIES OF PATIENTS 35
Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences? 35
Current management and future challenges in salivary glands cancer 34
Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer 33
Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience 32
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 31
LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS 30
Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma 30
Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer 29
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities? 28
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice 28
Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma 28
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma 25
Management of loco-regionally advanced squamous laryngeal cancer in elderly patients 25
Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma 25
Assessing Effective Engagement with Digital Behavior Change Intervention: The Case Study of the CAPABLE Project 24
Malignant salivary gland tumours in families with breast cancer susceptibility 22
Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM) 3
Generative AI and medical oncologists: Be curious, but cautious! 1
Sexual health in women and sexual-gender-minority patients with cancer: A nationwide survey on healthcare professional awareness and attitude on behalf of MITO and AIRO-gynecology group 1
Totale 4.503
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 0 0 1 0 0 0 2
2022/202315 1 0 0 0 1 1 0 0 10 0 2 0
2023/202461 1 6 0 1 1 4 10 3 5 2 11 17
2024/20251.171 9 14 21 18 13 179 104 87 264 46 112 304
2025/20263.253 225 211 222 388 364 132 467 138 293 290 338 185
Totale 4.503